Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Abroad (travel likely)Recruiting
Conditions
Locally Advanced · High-Risk · Rectal Cancer · MSS
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Nanfang Hospital Southern Medical University, Guangzhou, Guangdong, China
Study leads
Dehua Wu, MD
Principal Investigator
Nanfang Hospital, Southern Medical University